Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Sensydia Corporation | INDUSTRY |
Not provided
Not provided
Not provided
Non-significant risk device study to conduct evaluation of the performance of new device for monitoring of cardiac function (based on previous iterations 510(k) 173156)
This validation study will help to establish feasibility of using the CPS monitor to screen patients for ejection fraction (EF), CO, PASP and wedge pressure compared to a standard echocardiogram. No clinical decisions will be made as a result of the CPS device EF value and this measurement will be taken for comparison purposes only.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Cardiac Performance System (NSR) | Subjects will wear Cardiac Performance System (CPS) non-invasive device during their standard echocardiogram |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Cardiac Performance System (CPS) Device | Device | CPS is a passive measurement system that acquires signals from multiple sensor sources that monitor cardiac heart sounds. The passive sensor systems measure sound only and do not produce energy. The CPS system also includes a Patient Monitor device that acquires data from the sensors as well as from three standard ECG electrodes. The CPS system does not acquire or store any protected health information or any subject characteristics. The CPS system has received FDA clearance K173156. Note that the CPS system was previously named Integrated CardioRespiratory (ICR) system. The CPS is FDA cleared for the ejection fraction (EF) assessment which will be its intended use for this study. |
| Measure | Description | Time Frame |
|---|---|---|
| Cardiac Performance System electronic data for Ejection Fraction | Cardiac function measurement including left ventricle ejection fraction to report in percentage | 60 minutes during Echocardiography procedure |
| Cardiac Performance System electronic data for Cardiac Output | Cardiac function metric measurement including Cardiac Output to report in L/m | 60 minutes during Echocardiography procedure |
| Cardiac Performance System electronic data for Pulmonary Artery Pressure | Cardiac function metric measurement including Pulmonary Artery Pressure to report in mmHg. | 60 minutes during Echocardiography procedure |
| Cardiac Performance System electronic data for Pulmonary Artery Wedge Pressure | Cardiac function metric measurement including Pulmonary Artery Wedge Pressure to report in mmHg | 60 minutes during Echocardiography procedure |
| Echocardiography electronic data for Ejection Fraction | Cardiac function measurement including left ventricle ejection fraction to report in percentage | 60 minutes during Echocardiography procedure |
| Echocardiography electronic data for Cardiac Output | Cardiac function metric measurement including Cardiac Output to report in L/m | 60 minutes during Echocardiography procedure |
| Echocardiography electronic data for Pulmonary Artery Pressure |
Not provided
Not provided
Inclusion Criteria:
• Patients over 18 scheduled for a standard echocardiogram
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Patients scheduled for a standard echocardiogram
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Stephen L Esper, MD, MBA | University of Pittsburgh Medical Center | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| UPMC Montefiore Hospital | Pittsburgh | Pennsylvania | 15212 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D006331 | Heart Diseases |
| ID | Term |
|---|---|
| D002318 | Cardiovascular Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
|
Cardiac function metric measurement including Pulmonary Artery Pressure to report in mmHg. |
| 60 minutes during Echocardiography procedure |
| Echocardiography electronic data for Pulmonary Artery Wedge Pressure | Cardiac function metric measurement including Pulmonary Artery Wedge Pressure to report in mmHg | 60 minutes during Echocardiography procedure |